(Q41112035)

26 September 2017

1 reference

title

The effect of age on pharmacokinetics of antiepileptic drugs (English)

1 reference

26 September 2017

1 reference

Willmore LJ

1

1 reference

26 September 2017

publication date

1 January 1995

1 reference

26 September 2017

1 reference

26 September 2017

volume

36 Suppl 5

1 reference

26 September 2017

page(s)

S14-21

1 reference

Advanced Alzheimer's disease is a risk factor for late-onset seizures

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

A survey of epileptic disorders in southwest France: seizures in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Seizures after primary intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

The significance of myoclonic status epilepticus in postanoxic coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

The effect of age upon liver volume and apparent liver blood flow in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Drug metabolism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Implications of altered drug disposition in the elderly: studies of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Phenytoin dosage in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Pharmacokinetics of valproic acid in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Pharmacokinetics of valproic acid in young and elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Cytochrome P450 isozymes and antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

The effects of age on carbamazepine pharmacokinetics and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Effects of carbamazepine and its epoxide metabolite on amygdala-kindled seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

A rational guide to routine blood monitoring in patients receiving antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Factors influencing plasma phenobarbitone levels in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

Lorazepam kinetics in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB06005.X

10.1111/J.1528-1157.1995.TB06005.X

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference